Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Brain Neoplasms 15Glioblastoma 9Carcinoma, Non-Small-Cell Lung 9Gliosarcoma 7Central Nervous System Neoplasms 4Lung Neoplasms 3Oligodendroglioma 2Neuroblastoma 2Neoplasms 2Glioma 2Astrocytoma 2Untreated Childhood Anaplastic Astrocytoma 1Tongue Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Respiratory Tract Diseases 1Prostatic Neoplasms 1Parathyroid Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Meningioma 1Glioma, Subependymal 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Medullary 1Adenocarcinoma, Follicular 1

Interventions

Magnetic Resonance Spectroscopy 7Temozolomide 6Radiotherapy 5Surgical Procedures, Operative 3Imatinib Mesylate 3Biopsy 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3sargramostim 2Tamoxifen 2Donepezil 2Congresses as Topic 2Cisplatin 2Carboplatin 2temsirolimus 1lonafarnib 1gallium Ga 68 dotatate 1fluorodopa F 18 1entinostat 1carboxyamido-triazole 1aldesleukin 1Vinblastine 1Verteporfin 1Topotecan 1Thalidomide 1Surveys and Questionnaires 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Photochemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma, Subependymal × Gefitinib × CNS × Clear all
NCT00025675 2018-06-26

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
105 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡